Efficacy and Effectiveness of Antidepressants: Current Status of Research
The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Background: This paper examines the current status of research on the efficacy and effectiveness of antidepressants. Methods: This paper reviews four meta-analyses of efficacy trials submitted to America’s Food and Drug Administration (FDA) and analyzes STAR*D (Sequenced Treatment Alternatives to Relieve Depression), the largest antidepressant effectiveness trial ever conducted. Results: Meta-analyses of FDA trials suggest that antidepressants are only marginally efficacious compared to placebos and document profound publication bias that inflates their apparent efficacy. These meta-analyses also document a second form of bias in which researchers fail to report the negative results for the pre-specified primary outcome measure submitted to the FDA, while highlighting in published studies positive results from a secondary or even a new measure as though it was their primary measure of interest. The STAR*D analysis found that the effectiveness of antidepressant therapies was probably even lower than the modest one reported by the study authors with an apparent progressively increasing dropout rate across each study phase. Conclusions: The reviewed findings argue for a reappraisal of the current recommended standard of care of depression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the STAR-D trial, the largest naturalistic study of antidepressants so far conducted, the remission rate at one year for all participants taking antidepressants was 2.7% (108/4000), and 92.9% relapsed or dropped out (Pigott 2010).”
From Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults (2021) · cites this paper as Pigott 2010
In the citing paper
“Currently available antidepressant medications largely target monoamine pathways, but treatment of depression is only effective in about a third to a half of patients.1, 2”
From Association of depressive disorders, depression characteristics and antidepressant medication with inflammation (2012) · cites this paper as [1]
In the citing paper
“current treatment of depression is only effective in about a third to a half of patients,1, 2”
From Association of depressive disorders, depression characteristics and antidepressant medication with inflammation (2012) · cites this paper as [1]
In the citing paper
“In this study, 84 % of participants in this study answered in the affirmative to a question about whether they felt antidepressants had reduced their depression, a number well above that suggested by efficacy studies”
From ‘In my life antidepressants have been…’: a qualitative analysis of users’ diverse experiences with antidepressants (2016) · cites this paper as [26]
In the citing paper
“An understanding of users’ own experiences of antidepressant use is increasingly important in the context of growing doubts about the effectiveness of antidepressant treatment [5, 26], concerns about side effects [27] and withdrawal effects [28].”
From ‘In my life antidepressants have been…’: a qualitative analysis of users’ diverse experiences with antidepressants (2016) · cites this paper as [26]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879 · cited 1×
“recommendations for distinguishing between specific and nonspecific treatment effects, the first one being having an active placebo arm to reduce the likelihood of unblinding and thereby control the potential role of side effects in enhancing patients’ expectation of improvement. Real-World Effectiveness of Antidepres…”
BackgroundRush, A. J., Trivedi, M. H., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., Markowitz, J. C., Ninan, P. T., Kornstein, S., Manber, R., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01866-8 · Cited by 3,829 · cited 1×
“p. 129] (table 2 ). 2 Table 2. Survival analysis by treatment step of patients who entered continuing care in remission T02 As mentioned earlier, STAR*D was designed to identify the best next-step treatment for the many patients who fail to get adequate relief from their initial SSRI trial. Due to the high study dropo…”
MethodKirsch, I., Deacon, B. J., Huedo-Medina, T. B., Scoboria, A., Moore, T. J., & Johnson, B. T. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050045 · Cited by 2,442
Selective publication of antidepressant trials and its influence on apparent efficacy
Turner, E. H., Matthews, A. M., Linardatos, E., Tell, R. A., & Rosenthal, R. (2008) · New England Journal of Medicine · doi:10.1056/nejmsa065779 · Cited by 2,435
HARKing: Hypothesizing after the results are known
Kerr, N. L. (1998) · Personality and Social Psychology Review · doi:10.1207/s15327957pspr0203_4 · Cited by 1,989
Chan, A.-W., Hróbjartsson, A., Haahr, M. T., Gøtzsche, P. C., & Altman, D. G. (2004) · JAMA · doi:10.1001/jama.291.20.2457 · Cited by 1,845
The Existence of Publication Bias and Risk Factors for Its Occurrence
Dickersin, K. (1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03440100097014 · Cited by 1,417
Placebo Response in Studies of Major Depression: Variable, Substantial, and Growing
Walsh, B. T., Seidman, S. N., Sysko, R., & Gould, M. (2002) · JAMA · doi:10.1001/jama.287.14.1840 · Cited by 1,109 · cited 1×
“observed that early RCTs often enrolled hospitalized patients who were less responsive to placebo, whereas more recent trials typically enroll highly selected outpatients, contacted through mass media advertisements, who may be less severely depressed. In a meta-analysis of 75 RCTs published between 1981 and 2000, Wal…”
BackgroundSequenced treatment alternatives to relieve depression (STAR*D): Rationale and design
Rush, A. J., Fava, M., Wisniewski, S. R., Lavori, P. W., Trivedi, M. H., Sackeim, H. A., Thase, M. E., Nierenberg, A. A., Quitkin, F. M., Kashner, T. M., et al. (2004) · Controlled Clinical Trials · doi:10.1016/s0197-2456(03)00112-0 · Cited by 1,076 · cited 1×
“p. 739].The conclusion section of the research design article of STAR*D states: ‘STAR * D uses a randomized, controlled design to evaluate both the theoretical principles and clinical beliefs that currently guide the management of treatment-resistant depression in terms of symptoms, function, satisfaction, side-effect…”
Background
Research works printed but not linked: 9
- 10.1001%2Fjama.263.10.1385 · DOI
- 10.1176%2Fappi.ajp.163.7.1161 · doi:10.1176/appi.ajp.163.7.1161 · Paper page
- 10.1176%2Fappi.ajp.163.9.1519 · DOI · Paper page
- 10.1176%2Fappi.ajp.163.9.1531 · DOI
- 10.1176%2Fappi.ajp.163.11.1905 · doi:10.1176/appi.ajp.163.11.1905 · Paper page
- 10.1176%2Fappi.ajp.164.5.739 · DOI · Paper page
- 10.1001%2Fjama.287.13.1646 · DOI
- 10.1159%2F000235736 · DOI · Paper page
- 10.1016%2FS0895-4356%2899%2900161-4 · DOI · Paper page
Cited by
Items 301–345 of 345
A Sociological Approach and the 7x4 Field are Need in Dealing with Depression
Heiska, J. (2015) · Asian Journal of Pharmacy Nursing and Medical Sciences · doi:10.24203/ajpnms.v3i3.2906.g1627
Anderson, I. M. (2011) · Psychological Medicine · doi:10.1017/s0033291711000456
“Now, however, there is increasing questioning of the benefits of antidepressants due to a range of factors ranging at one end from distrust of ‘big Pharma’ and concerns about medicalizing distress (Moncrieff, 2008) through to questioning how well antidepressants actually work in the treatment of depression (e.g. Kirsc…”
BackgroundFjellström, E. (2015) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Allen, R. W. (2014) · Digital Commons - East Tennessee State University (East Tennessee State University)
Reeve‐Johnson, L. (2015) · Veterinary Record · doi:10.1136/vr.h4836
Whitaker, R., & Cosgrove, L. (2015) · Palgrave Macmillan US eBooks · doi:10.1057/9781137516022_7
Food and Mood: An Investigation Into the Association Between Diet Quality and Depressive Symptoms
Quehl, R. (2015) · The Atrium (University of Guelph) · Cited by 1
Joao, P., Anastassia, B., Araújo-Correia, M., Andreia, B. V., Strekalova, T. V., & Harry, W. M. S. (2016) · Translational Neuroscience and Clinics · doi:10.18679/cn11-6030/r.2016.021
Insulin receptor sensitization improves affective pathology in various mouse models
Nunes, J. P. D. C. A. V. (2015) · Research Publications (Maastricht University) · doi:10.26481/dis.20151221jc
Screening of a Histone Methyltransferase Inhibitor in Animal Models of Psychiatric Illness
Kosowan, J. (2014) · TSpace (University of Toronto)
Guille, C., Cortese, B. M., & Uhde, T. W. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-1703-7.10055-6
Breaking the Depression Deadlock- Rethinking Depression Globally
Celie, J. E., Moloney, P., & Verhaeghe, P. (2018) · Journal of Mental Disorders and Treatment · doi:10.4172/2471-271x.1000167 · Cited by 1
“Pigott [69] conclude that the effectiveness of antidepressants is even lower than the modest effect sizes reported in the largest antidepressant effectiveness trial ever conducted (STAR*D).”
ResultCulture-related Depression in Taiwanese Women and the Application of The BodyMind Approach TM
Lin, Y. (2016) · University of Hertfordshire Research Archive (University of Hertfordshire) · doi:10.18745/th.23623 · Cited by 7
Oxytocin and Social Sensitivity: Implications for Vulnerability to Stress and Depressive Symptoms
McQuaid, R. J. (2015) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2015-11083
Bhavana, M. S., Likhitha, M., Swathi, T., Teja, A. C. N., Baba, K. H., & Roby, K. A. C. (2021) · INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH · doi:10.36106/ijsr/4000123
Monitoring the effects of therapeutic interventions in depression through self-assessments
Moragrega, I., Bridler, R., Möhr, C., Possenti, M., Rochat, D., Parramon, J. S., & Stassen, H. H. (2021) · Research in Psychotherapy Psychopathology Process and Outcome · doi:10.4081/ripppo.2021.548 · Cited by 1
Rasmijn, A. (2022) · Research Publications (Maastricht University) · doi:10.26481/dis.20220315ar · Cited by 1
Wang, T. (2020) · Springer eBooks · doi:10.1007/978-3-030-54666-3_15
Oxytocin, Social Interactions and Coping: Implications for Depression
McInnis, O. A. (2016) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2016-11454
Hasler, F. (2023) · transcript Verlag eBooks · doi:10.14361/9783839445716 · Cited by 3
Addictions, concepts généraux, évaluation et facteurs de vulnérabilité
Graziani, P., & Romo, L. (2023) · Elsevier eBooks · doi:10.1016/b978-2-294-77964-0.00001-5
Schummer, G. J., & Sguigna, T. (2024) · NeuroRegulation · doi:10.15540/nr.11.1.92
Musikhören bei Depression und Demenz: von der Hirnforschung zur klinischen Anwendung
Grebosz‐Haring, K., Bernatzky, G., Wendtner, F., & Kreutz, G. (2024) · Springer eBooks · doi:10.1007/978-3-662-67506-9_9 · Cited by 2
Dombrádi, K. (2024) · Belvedere Meridionale · doi:10.14232/belv.2024.1.15 · Cited by 1
Schmaling, K. B., & Kaplan, R. M. (2025) · Cambridge University Press eBooks · doi:10.1017/9781009391733.016
Case Study: Antidepressant Medications
Schmaling, K. B., & Kaplan, R. M. (2025) · Cambridge University Press eBooks · doi:10.1017/9781009391733.020
Francis, A. J. A., Bajpai, A., Balasubramani, N. P., Tiwari, H. P., Singh, S., Chawla, K., Singh, A. D., Chaudhari, D., & Balasubramani, P. P. (2025) · medRxiv · doi:10.1101/2025.03.07.25323496 · Cited by 1
“(Bauer et al., 2007; Fochtmann & Gelenberg, 2005; Pigott et al., 2010; Quitkin et al., 2003).”
Vilar, A., Bayes‐Marin, I., Álvarez-Salazar, S., Piqueras‐Marques, J., Vila, S., & Forero, C. G. (2025) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2025.06.010
Francis, A. J. A., Bajpai, A., Tiwari, H. P., Balasubramani, N. P., & Balasubramani, P. P. (2025) · Research Square · doi:10.21203/rs.3.rs-6161499/v1 · Cited by 1
Francis, A. J. A., Bajpai, A., Tiwari, H. P., Balasubramani, N. P., & Balasubramani, P. P. (2025) · Research Square · doi:10.21203/rs.3.rs-7345538/v1
Overview of Depression with the Help of the 7x4-field
Heiska, J. (2025) · International Journal of Psychological and Brain Sciences · doi:10.11648/j.ijpbs.20251005.13
Patient and Physician Accounts of Antidepressant Requests in Primary Care
Letourneau, J. (2013) · University Library - University of Saskatchewan (University of Saskatchewan)
Listening to Music in Depression and Dementia: From Brain Research to Clinical Application
Grebosz‐Haring, K., Bernatzky, G., Wendtner, F., & Kreutz, G. (2025) · Neurocultural health and wellbeing · doi:10.1007/978-3-662-72175-9_7
Bilu, Y., El‐Hay, T., Helbitz, T., Delgadillo, J., & Atzil–Slonim, D. (2026) · BMC Psychiatry · doi:10.1186/s12888-025-07745-9 · Cited by 1
Garg, A., Gulati, K., Jasti, N., Shivakumar, V., Udupa, K., & Ramakrishna, K. K. (2026) · Annals of Neurosciences · doi:10.1177/09727531251368081
“8 However, low remission rates, higher relapse, drug intolerance, and reduction in Heart Rate Variability (HRV) associated with antidepressants 9,10 make it essential to find an alternative treatment that can augment the effects of antidepressants.”
Mental health promotion through soccer in high-risk communities: a narrative review
Нарзикулова, Д. Х., Kozokboeva, D., Gayupova, S., TOSHBOYEVA, B., Jonibek, K., Ostonov, O., qizi, H. B. H., & Egamberganova, D. (2026) · Discover Social Science and Health · doi:10.1007/s44155-026-00358-x · Cited by 1
“Furthermore, the efficacy of antidepressants relative to placebos remains modest, even after accounting for publication and reporting biases [40].”
Gellman, J., Zemliana, N. A., Loterstein, Y., Dory, E. K., Matas, D., Shoval, G., Sharon, E., Koman, I. E., Zalsman, G., Koren, L., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27073177
Constantino, J. L., Freimann, T. S., van Dalfsen, J. H., van der Meij, A., Veraart, J. K. E., Smith-Apeldoorn, S. Y., Schoevers, R. A., & Kamphuis, J. (2026) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2026.06.013
Francis, A. J. A., Bajpai, A., Balasubramani, N. P., Tiwari, H. P., Singh, S., Chawla, K., Singh, A. D., Chaudhari, D., & Balasubramani, P. P. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1823806
Atkins, B., Smith, C., Bhattacharya, D., & Scott, S. (2026) · Behavioral Sciences · doi:10.3390/bs16071251
“Antidepressants provide symptom relief during an acute life event (Pigott et al., 2010).”
The Roles of Transcription Factor Ets-1 in Neurological Disorders
Jantaratnotai, N., & McLarnon, J. G. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06199-8
“Current antidepressants can treat only about 50% of patients and there is interest in finding and testing novel antidepressants [110, 111].”
L'approche transdiagnostique en psychopathologie
der Linden, M. V. (2026) · Dunod eBooks · doi:10.3917/dunod.mones.2026.01.0016
The HPA axis and GABA-Glutamate Systems as Potential Antidepressant Targets in Prostate Cancer
Sharpley, C. F. (2011) · The Open Prostate Cancer Journal · doi:10.2174/1876822901104010001 · Cited by 1
Metadata
- Authors
- Pigott, H. E., Leventhal, A. M., Alter, G. S., & Boren, J. J.
- Affiliations
- American University (US)
- ORCID
- Pigott, H. Edmund
- Venue
- Psychotherapy and Psychosomatics
- Publisher
- S. Karger AG
- Published
- 2010
- Volume
- 79
- Issue
- 5
- Pages
- 267-279
- ISSN
- 0033-3190 (ISSN-L)
- 1423-0348
- OpenAlex
- W2020265264
- Cited by
- 347
- References
- 58
- Citations by year
- 2026: 10 · 2025: 16 · 2024: 15 · 2023: 21 · 2022: 13 · 2021: 23 · 2020: 18 · 2019: 22 · 2018: 22 · 2017: 16 · 2016: 19 · 2015: 42 · 2014: 22 · 2013: 20 · 2012: 26
- FWCI
- 3.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Psychotherapy and Psychosomatics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Keywords
- antidepressants, depression, antidepressant efficacy, publication bias, STAR*D trial, meta-analysis, selective outcome reporting, dropout rates
- MeSH terms
- Antidepressive Agents, Depressive Disorder, Humans, Meta-Analysis as Topic, Randomized Controlled Trials as Topic, Treatment Outcome, Publication Bias, Secondary Prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.